ACTIVE SUBSTANCE / INN

AZILSARTAN MEDOXOMIL

Brand name(s): Ipreziv, Edarbi, AZILSARTAN MEDOXOMIL
FDA LISTED
EMA LISTED
WITHDRAWN
AUTHORISED
NONE (TENTATIVE APPROVAL)
Hypertension
ANDA219062
ACTIVE SUBSTANCE
Azilsartan Medoxomil
REGULATORS
FDA · EMA
SPONSORS / MAH
HETERO LABS LIMITED, Takeda Pharma A/S
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AZILSARTAN MEDOXOMILANDA219062HETERO LABS LIMITEDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EdarbiTakeda Pharma A/SAuthorised07/12/2011Hypertension
IprezivTakeda Pharma A/SWithdrawn07/12/2011Hypertension

FULL INTELLIGENCE ON AZILSARTAN MEDOXOMIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →